Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Heron Therapeutics Inc (HRTX) vs Novo Nordisk A/S (NVO) Price & Performance

Heron Therapeutics IncTrade
Novo Nordisk A/STrade

Price performance (Past 24H)

Key statistics

Heron Therapeutics Inc vs Novo Nordisk A/S — how do they compare? Heron Therapeutics Inc trades at $0.32 (market cap $61.47M), while Novo Nordisk A/S trades at $45.97 (market cap $207.85B). The key difference: Novo Nordisk A/S is far larger — about 3381.3× Heron Therapeutics Inc's market cap, and Novo Nordisk A/S pays a 3.81% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.

HRTXNVO
Market Cap
$61.47M$207.85B
Sector
HealthHealth
52-Week High
$1.49$63.98
52-Week Low
$0.32$35.29
Enterprise Value
$168.21M$222.55B
Dividend Yield
3.81%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.

Read more on HRTX

About Novo Nordisk A/S

With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Read more on NVO